Myopathy associated with chronic orlistat consumption: A case report

Neuromuscular Disorders

Volumn 18, Issue 5, 2008, Pages 410-412

  Ringman, John M ^a   Mozaffar, Tahseen ^b  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

CK; Coenzyme Q10; Creatine phosphokinase; Myopathy; Orlistat; Statin; Weight loss

Indexed keywords

CREATINE KINASE; TETRAHYDROLIPSTATIN;

ADULT; ARTICLE; CASE REPORT; CREATINE KINASE BLOOD LEVEL; DRUG USE; DRUG WITHDRAWAL; ELECTROMYOGRAM; FASCICULATION; HUMAN; MALE; MUSCLE TWITCH; MYOPATHY; NERVE CONDUCTION; OBESITY; PHYSICAL EXAMINATION; PRIORITY JOURNAL;

ADULT; ANTI-OBESITY AGENTS; CREATINE KINASE; HUMANS; LACTONES; MALE; MUSCULAR DISEASES; TREATMENT OUTCOME; UBIQUINONE;

EID: 43449115665     PISSN: 09608966     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.nmd.2008.03.005     Document Type: Article

References (13)

1. Antons K.A., Williams C.D., Baker S.K., and Phillips P.S. Clinical perspectives of statin-induced rhabdomyolysis. Am J Med 119 5 (2006) 400-409
2. Noel B. Autoimmune disease and other potential side-effects of statins. Lancet 363 9425 (2004) 2000
3. Cartwright M.S., Jeffery D.R., Nuss G.R., and Donofrio P.D. Statin-associated exacerbation of myasthenia gravis. Neurology 63 11 (2004) 2188
4. Schick B.A., Laaksonen R., Frohlich J.J., Paiva H., Lehtimaki T., Humphries K.H., et al. Decreased skeletal muscle mitochondrial DNA in patients treated with high-dose simvastatin. Clin Pharmacol Ther 81 5 (2007) 650-653
5. Thomas J.E., Lee N., and Thompson P.D. Statins provoking MELAS syndrome. A case report. Eur Neurol 57 4 (2007) 232-235
6. De Pinieux G., Chariot P., Ammi-Said M., Louarn F., Lejonc J.L., Astier A., et al. Lipid-lowering drugs and mitochondrial function: effects of HMG-CoA reductase inhibitors on serum ubiquinone and blood lactate/pyruvate ratio. Br J Clin Pharmacol 42 3 (1996) 333-337
7. Berthold H.K., Naini A., Di Mauro S., Hallikainen M., Gylling H., Krone W., et al. Effect of ezetimibe and/or simvastatin on coenzyme Q10 levels in plasma: a randomised trial. Drug Saf 29 8 (2006) 703-712
8. Hill M.D., and Bilbao J.M. Case of the month: February 1999-54 year old man with severe muscle weakness. Brain Pathol 9 3 (1999) 607-608
9. Shek A., and Ferrill M.J. Statin-fibrate combination therapy. Ann Pharmacother 35 7-8 (2001) 908-917
10. Havranek J.M., Wolfsen A.R., Warnke G.A., and Phillips P.S. Monotherapy with ezetimibe causing myopathy. Am J Med 119 3 (2006) 285-286
11. Torgerson J.S., Hauptman J., Boldrin M.N., and Sjostrom L. XENical in the prevention of diabetes in obese subjects (XENDOS) study: a randomized study of orlistat as an adjunct to lifestyle changes for the prevention of type 2 diabetes in obese patients. Diabetes Care 27 1 (2004) 155-161
12. Kridel S.J., Axelrod F., Rozenkrantz N., and Smith J.W. Orlistat is a novel inhibitor of fatty acid synthase with antitumor activity. Cancer Res 64 6 (2004) 2070-2075
13. Filippatos T.D., Derdemezis C.S., Gazi I.F., Nakou E.S., Mikhailidis D.P., and Elisaf M.S. Orlistat-associated adverse effects and drug interactions: a critical review. Drug Saf 31 1 (2008) 53-65